David Heupel
David Heupel
guidance line stock
The 2007 and 2008 guidance is in line with expectations. And the stock is back down after a pretty big move.
compete dollars eighty number rationally
Eighty dollars is a 'wow' number ? I don't think there's any way J&J can rationally compete with that.
companies good move seen
We've seen a lot of pharmaceutical companies move out of their non-core businesses. It's a pretty good move.